The EUR/USD has been trading in a narrow range between 1.15 and 1.19 in recent months, with positive and negative economic factors on both sides of the Atlantic largely offsetting each other, UBS ...

Forward bookings for 2026 remain strong, with £1.5 billion in revenues already committed. Informa completed a £350 million share buyback in 2025 and has launched a new program for at least £200 ...

As a result of the adjustment, BKW lowered its outlook for 2025 operating profit. The group now expects EBIT of around 540 million to 560 million Swiss francs for the year. Excluding the one-off write ...

Investing.com -- Virbac shares rose over 4% after the animal health group reported a fourth-quarter revenue that missed ...

DFS Furniture PLC (LON:DFSD), the UK’s market leading upholstered furniture retailer, saw its shares surge 6.8% on Tuesday ...

US dollar weakens as trade war fears and Fed independence concerns pressure sentiment. EUR/USD may resume an uptrend if price holds above the 1.17 resistance zone. US GDP and PCE data could shape rate ...

Investing.com -- Big Yellow Group reported third-quarter revenue of £52.3 million, up from £51 million a year earlier, as higher net rents helped offset lower occupancy during a seasonally weaker ...

Investing.com - European stocks retreated Tuesday, adding to the previous session’s sharp losses as the concern of further ...

Investing.com -- AstraZeneca will delist its American Depositary Shares and debt securities from Nasdaq and complete a direct listing on the New York Stock Exchange, the company announced Tuesday. The ...

Investing.com -- Midwich Group plc (LON:MIDW), a global specialist audio visual distributor, on Tuesday reported its full-year 2025 revenue is expected to be approximately £1.3 billion, matching 2024 ...

Under the agreement, Shionogi will increase its holding in ViiV Healthcare to 21.7%, while GSK will maintain a 78.3% stake. To facilitate this change, ViiV Healthcare will issue new shares to Shionogi ...

Investing.com -- Japan’s Shionogi & Co (TYO:4507) said on Tuesday it would pay $2.13 billion for new shares in joint venture ViiV Healthcare, increasing its stake in the HIV drugmaker to 21.7% as U.S.